Rogers (ROG) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual Meeting scheduled for May 5, 2025, to be held virtually; record date is February 26, 2025.
Shareholders will vote on electing nine directors, ratifying PwC as auditor, and approving executive compensation on an advisory basis.
Board recommends voting FOR all director nominees and proposals.
Voting matters and shareholder proposals
Proposals include election of nine directors, ratification of PwC as independent auditor for 2025, and advisory approval of executive compensation.
Each share of common stock is entitled to one vote per director nominee and proposal.
Board recommends FOR all proposals.
Board of directors and corporate governance
Board expanded to nine members in 2025; eight of nine directors are independent.
Board committees: Audit, Compensation & Organization, and Nominating, Governance & Sustainability, all comprised of independent directors.
Board Chair is independent and separate from CEO; annual board and committee self-evaluations conducted.
Majority vote policy for uncontested elections; directors must submit resignation if not receiving majority support.
96% director attendance at meetings in 2024.
Latest events from Rogers
- Q4 sales and margins rose on cost savings; 2026 outlook projects continued growth.ROG
Q4 202518 Feb 2026 - Q4 results met guidance; cost controls and innovation support H2 2025 recovery plans.ROG
Q4 20243 Feb 2026 - Gross margin and adjusted EPS improved in Q2, with EMS growth offsetting AES softness.ROG
Q2 20242 Feb 2026 - Strong growth in EV and high-tech markets, with margin expansion and global innovation focus.ROG
Stifel 2024 Cross Sector Insight Conference31 Jan 2026 - Earnings beat guidance, but sales fell on weak EV/HEV demand; Q4 outlook remains cautious.ROG
Q3 202418 Jan 2026 - Q1 2025 sales fell but cash rose; Q2 guidance stable despite ongoing tariff risks.ROG
Q1 202527 Dec 2025 - Operational improvements and innovation in high-growth markets drive optimism for H2 recovery.ROG
Gabelli Funds' 16th Annual Specialty Chemicals Symposium19 Dec 2025 - Director elections, auditor ratification, and say-on-pay up for vote at May 2025 meeting.ROG
Proxy Filing2 Dec 2025 - Q2 2025 saw sequential sales growth, curamikⓇ impairments, and major restructuring.ROG
Q2 202516 Nov 2025